Astrazeneca opens a $ 300 million cell therapy manufacturing facility in Maryland

Astrazeneca was invested in $ 3.5 billion America InnovationIn order to treat cancer patients, the United States opened a US-owned company in Maryland.

A new $ 300 million facility in the UK pharmaceutical giant Rockville has symbolized the confidence of the American “global leader of the global leader of the”.

“We understand that we do because it is a danger of life and health.” “We chose to do this in the province of Maryland, because we believe in an incredible talent, scientific leadership and the spirit of cooperation.”

AstraRazeneca, as a demand, Covid-19 vaccine will withdraw, rare side effects

In the operation, the vehicle will use a relatively new cancer treatment called car-t cell therapy to help Blood cancers LENFOMA AND LOSEMY.

Andrew Gordon, who survived a cancer diagnosed with more than one myeloma in 2013, said he was using car-t cell therapy to fight the disease after the relap.

“This is really a leading edge of cancer research,” he said. “As patients, we are so grateful to Astrazeneca for the work they want to do here.”

Alternative cancer treatment can replace chemicals and surgery, offers learning

The opening of the new facility is in the comments released in recent weeks in the last weeks of the CEO of AstraZeneca Pascal Soriotun. He said that compared to other areas such as Europe, it can be more attractive for pharmaceutical companies. To Reuters.

“The European GDP spends a significantly lower part of US more innovative drugs, and in increasing the ability to protect the health of his people,” Soriot said, “Soriot said.

Financial markets scream on Trump tariffs

President Donald Trump The Great American Innovation – recently pushed for a trillion-dollar spike in US investments such as Toyota, Amazon, Johnson & Johnson & Johnson and more. During the first 100 days of the second term, the list of Trump’s winners was published by the White House, AstraZeneca admitted that the growing investment was invested in American production.

In November, $ 3.5 billion in investment in US research and production was announced for the first time. This includes the Research and Development Center In MassachusettsAccording to the production company in Texas, the next generation production enterprise and more for biology in Maryland, according to the drug producers.

Get the fox work on the way by clicking here

At present, Astrazeneca’s US operations produce 43% of global income, the company hopes to represent half of the United States until 2030.

“We believe that 4,200 American employees and the US-made network will be built of more than 9 billion doses produced every year, the future of developed drugs.